Home › NDC Lookup › RxCUI directory › RxCUI 2630853

0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovre] — RxCUI 2630853

Name: 0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovre] (RxCUI 2630853)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2630853 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2630853

Official name0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovre]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as0.1 ML Syfovre 150 MG/ML Injection; SYFOVRE 15 MG in 0.1 ML Injection; Syfovre 15 MG per 0.1 ML Injection

FDA products mapped1

Package NDCs mapped4

Reported Medicaid activity (SDUD)6,994 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegcetacoplan Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Empaveli works by calming down part of your immune system — the complement system — which is great for treating your condition, but it also makes it harder for your body to fight o...
Why do I have to get vaccinations before starting Empaveli? Can't I just start right away?
Most people notice some redness, mild swelling, bruising, itching, or soreness where the infusion goes in — this is the most commonly reported side effect with Empaveli. The good n...
What does the injection site reaction feel like, and is it something to worry about?

📖 Read our full Pegcetacoplan Injection guide →

🕸️ Concept Web — How 0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovre] RxCUI 2630853 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Pegcetacoplan 2557372 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Syfovre 2630849 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pegcetacoplan Injection 2557385 SCDF
- Pegcetacoplan Injectable Product 2557384 SCDG
- Pegcetacoplan Injection [Syfovre] 2630852 SBDF
- Syfovre Injectable Product 2630851 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.1 ML pegcetacoplan 150 MG/ML Injection 2630847 SCD
- Pegcetacoplan 150 MG/ML 2630846 SCDC
- Pegcetacoplan 150 MG/ML [Syfovre] 2630850 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.1 ML pegcetacoplan 150 MG/ML Injection SCD · 2630847
Pegcetacoplan 150 MG/ML SCDC · 2630846
Pegcetacoplan Injection SCDF · 2557385
Pegcetacoplan Injectable Product SCDG · 2557384

Brand-Name Concepts

Pegcetacoplan 150 MG/ML [Syfovre] SBDC · 2630850
Pegcetacoplan Injection [Syfovre] SBDF · 2630852
Syfovre Injectable Product SBDG · 2630851
Syfovre BN · 2630849

📦 FDA Products & Package NDCs

1 product · 4 package NDCs

4 package NDCs map to RxCUI 2630853 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
73606-0020-01	1 VIAL, GLASS in 1 CARTON (73606-020-01) / 3 mL in 1 VIAL,...	Syfovre	Apellis Pharmaceuticals, Inc.	2023-02-17
73606-0020-02	1 VIAL, GLASS in 1 CARTON (73606-020-02) / 3 mL in 1 VIAL,...	Syfovre	Apellis Pharmaceuticals, Inc.	2025-11-07
73606-0020-11	1 VIAL, GLASS in 1 CARTON (73606-020-11) / 3 mL in 1 VIAL,...	Syfovre	Apellis Pharmaceuticals, Inc.	2023-02-17
73606-0020-12	1 VIAL, GLASS in 1 CARTON (73606-020-12) / 3 mL in 1 VIAL,...	Syfovre	Apellis Pharmaceuticals, Inc.	2025-11-07

Observed labelers: Apellis Pharmaceuticals, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2781	Inj, pegcetacoplan, 1mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.